Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
UkraineAll medications by this manufacturer
-
Salofalk
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 500 mg ATC: A07EC02
-
Salofalk
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
-
Salofalk
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 500 mg ATC: A07EC02